AI assistant
VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2017
Oct 31, 2017
29864_dirs_2017-10-31_ea9bf6c6-b817-47e6-8de2-1024ef014e27.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2017-10-31
Reporting Person: Sachdev Amit (EVP, CRO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-10-31 | Common Stock | S | 900 | $142.40 | Disposed | 89810 | Direct |
| 2017-10-31 | Common Stock | S | 2800 | $143.49 | Disposed | 87010 | Direct |
| 2017-10-31 | Common Stock | S | 17362 | $144.47 | Disposed | 69648 | Direct |
| 2017-10-31 | Common Stock | S | 12438 | $145.26 | Disposed | 57210 | Direct |
| 2017-10-31 | Common Stock | S | 3200 | $146.53 | Disposed | 54010 | Direct |
| 2017-10-31 | Common Stock | S | 2200 | $147.70 | Disposed | 51810 | Direct |
| 2017-10-31 | Common Stock | S | 1000 | $148.35 | Disposed | 50810 | Direct |
| 2017-10-31 | Common Stock | S | 100 | $149.34 | Disposed | 50710 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 882 | Indirect |
Footnotes
F1: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1.
F2: Open market sales reported on this line occurred at a weighted average price of $142.40 (range $141.83 to $142.70).
F3: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F4: Open market sales reported on this line occurred at a weighted average price of $143.49 (range $142.87 to $143.85).
F5: Open market sales reported on this line occurred at a weighted average price of $144.47 (range $143.90 to $144.89).
F6: Open market sales reported on this line occurred at a weighted average price of $145.26 (range $144.93 to $145.87).
F7: Open market sales reported on this line occurred at a weighted average price of $146.53 (range $146.16 to $147.14).
F8: Open market sales reported on this line occurred at a weighted average price of $147.70 (range $147.18 to $148.15).
F9: Open market sales reported on this line occurred at a weighted average price of $148.35 (range $148.19 to $148.70).